Moneycontrol
Sep 21, 2011 11:00 PM IST | Source: CNBC-TV18

Red tapism hurting biotechnology industry in India: Shaw

Expressing concerns over the bureaucratic bottlenecks involved in conducting clinical research and trials in biotechnology sector in India, the industry experts today appealed to the regulatory authorities to stick to the "rule book" rather than "subjectivity".

Red tapism hurting biotechnology industry in India: Shaw

Expressing concerns over the bureaucratic bottlenecks involved in conducting clinical research and trials in biotechnology sector in India, the industry experts today appealed to the regulatory authorities to stick to the "rule book" rather than "subjectivity".


Yesterday, in a strongly worded letter, commerce minister Anand Sharma shot off a letter to prime minister Manmohan Singh where he criticized the delay in the recommendations of the Maira Committee on foreign direct investment (FDI) in the pharma sector.


On FDI in pharma, Shaw says, 

Follow us on
Available On